10/19/2026
🚨 FDA PEPTIDE UPDATE: WE'RE ONE STEP CLOSER! 🧬
Some encouraging news for patients interested in peptide therapy!
Following the FDA's July 23–24, 2026 advisory committee meetings, another important step has been taken.
📅 October 14, 2026: The FDA submitted a proposed policy titled Interim Access Policy for Compounding Using Certain Peptides to the White House Office of Management and Budget (OMB) for review.
This could potentially create a pathway for certain peptides, including BPC-157, TB-500, and others, to become more accessible through properly licensed compounding pharmacies.
⚠️ What does this mean?
These peptides are NOT FDA-approved medications, and the proposed policy does not yet authorize their compounding. However, this represents another step toward potentially expanding access under appropriate medical supervision.
🔴 OUR COMMITMENT AT GAMEDAY SOLON
At Gameday Men's Health Solon, patient safety always comes first.
We work exclusively with appropriately licensed, compliant pharmacies registered with the Ohio Board of Pharmacy, ensuring our patients receive medications through regulated pharmacy channels—not questionable online research peptide suppliers.
We're actively monitoring these developments and will keep our patients and community informed as the FDA moves forward.
The future of peptide therapy may be changing, and we're paying attention!
📍 Gameday Men's Health Solon
📞 440-201-4919
🌐 https://gamedaymenshealth.com/solon-oh/
Real Team. Real Medicine. Real Life Solutions.